MX393998B - Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial - Google Patents
Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelialInfo
- Publication number
- MX393998B MX393998B MX2019012051A MX2019012051A MX393998B MX 393998 B MX393998 B MX 393998B MX 2019012051 A MX2019012051 A MX 2019012051A MX 2019012051 A MX2019012051 A MX 2019012051A MX 393998 B MX393998 B MX 393998B
- Authority
- MX
- Mexico
- Prior art keywords
- proteins
- barrier function
- treatment
- therapeutic proteins
- epithelial barrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Prostheses (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482963P | 2017-04-07 | 2017-04-07 | |
| US201762607706P | 2017-12-19 | 2017-12-19 | |
| US201762611334P | 2017-12-28 | 2017-12-28 | |
| PCT/US2018/026447 WO2018187682A1 (en) | 2017-04-07 | 2018-04-06 | Proteins for the treatment of epithelial barrier function disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019012051A MX2019012051A (es) | 2020-02-12 |
| MX393998B true MX393998B (es) | 2025-03-24 |
Family
ID=63710147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012051A MX393998B (es) | 2017-04-07 | 2018-04-06 | Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial |
| MX2022008842A MX2022008842A (es) | 2017-04-07 | 2019-10-07 | Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022008842A MX2022008842A (es) | 2017-04-07 | 2019-10-07 | Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10251933B2 (enExample) |
| EP (1) | EP3606542A4 (enExample) |
| JP (2) | JP7789303B2 (enExample) |
| KR (2) | KR102903277B1 (enExample) |
| CN (1) | CN110769844B (enExample) |
| AU (2) | AU2018248324B2 (enExample) |
| CA (1) | CA3059354A1 (enExample) |
| IL (1) | IL269853A (enExample) |
| MX (2) | MX393998B (enExample) |
| SG (1) | SG11201909334TA (enExample) |
| TW (1) | TWI797116B (enExample) |
| WO (1) | WO2018187682A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10251933B2 (en) | 2017-04-07 | 2019-04-09 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| EP3773644A4 (en) * | 2018-04-06 | 2021-06-02 | Second Genome, Inc. | PROTEINS FOR TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS |
| JP2022512639A (ja) * | 2018-10-09 | 2022-02-07 | セカンド ゲノム インコーポレイテッド | 上皮バリア機能障害の治療に有効なタンパク質を送達するためのラクトコッカス・ラクティス発現系 |
| US20210079086A1 (en) * | 2019-08-21 | 2021-03-18 | Astrazeneca Collaboration Ventures, Llc | Use of Brazikumab to Treat Crohn's Disease |
| EP4087859A4 (en) * | 2020-01-10 | 2024-02-14 | National Taipei University of Technology | PEPTIDE INTERACTING WITH THE TOLL-LIKE RECEPTOR 2 AND COMPOSITION THEREOF |
| CN113773364B (zh) * | 2021-08-25 | 2023-04-28 | 无锡市儿童医院 | 小分子肽及其制备方法和应用 |
| JP2025542567A (ja) * | 2022-11-04 | 2025-12-26 | ミンク セラピューティクス，インコーポレイティッド | Ｂ細胞成熟抗原（ｂｃｍａ）キメラ抗原受容体インバリアントナチュラルキラーｔ細胞及びその用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5571702A (en) | 1991-03-29 | 1996-11-05 | Genentech, Inc. | Amplification method for detection of human PF4A receptors |
| AR053579A1 (es) * | 2005-04-15 | 2007-05-09 | Genentech Inc | Tratamiento de la enfermedad inflamatoria intestinal (eii) |
| ES2568938T3 (es) | 2009-04-28 | 2016-05-05 | Vanderbilt University | Composiciones y procedimientos de tratamiento de trastornos que implican apoptosis de células epiteliales |
| GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| JP2014093482A (ja) | 2012-11-06 | 2014-05-19 | Toshiba Corp | 固体撮像装置の製造方法および固体撮像装置 |
| GB201306536D0 (en) * | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| WO2015014973A2 (en) * | 2013-07-31 | 2015-02-05 | Institut National De La Recherche Agronomique | Use of specific glycoside phosphorylases for the implementation of phosphorolysis or reverse phosphorolysis reactions |
| WO2016203221A1 (en) * | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| US10251933B2 (en) | 2017-04-07 | 2019-04-09 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) * | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11174293B2 (en) | 2017-06-02 | 2021-11-16 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
-
2018
- 2018-04-06 US US15/947,263 patent/US10251933B2/en active Active
- 2018-04-06 CA CA3059354A patent/CA3059354A1/en active Pending
- 2018-04-06 US US16/603,507 patent/US11207376B2/en active Active
- 2018-04-06 KR KR1020237032575A patent/KR102903277B1/ko active Active
- 2018-04-06 AU AU2018248324A patent/AU2018248324B2/en active Active
- 2018-04-06 KR KR1020197032830A patent/KR20200003821A/ko not_active Ceased
- 2018-04-06 EP EP18781398.5A patent/EP3606542A4/en active Pending
- 2018-04-06 CN CN201880037987.0A patent/CN110769844B/zh not_active Expired - Fee Related
- 2018-04-06 JP JP2019554976A patent/JP7789303B2/ja active Active
- 2018-04-06 SG SG11201909334T patent/SG11201909334TA/en unknown
- 2018-04-06 MX MX2019012051A patent/MX393998B/es unknown
- 2018-04-06 WO PCT/US2018/026447 patent/WO2018187682A1/en not_active Ceased
- 2018-04-09 TW TW107112165A patent/TWI797116B/zh active
-
2019
- 2019-10-06 IL IL26985319A patent/IL269853A/en unknown
- 2019-10-07 MX MX2022008842A patent/MX2022008842A/es unknown
-
2023
- 2023-04-24 US US18/305,899 patent/US20240066095A1/en active Pending
- 2023-05-08 AU AU2023202844A patent/AU2023202844A1/en not_active Abandoned
- 2023-12-11 JP JP2023208379A patent/JP2024037834A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024037834A (ja) | 2024-03-19 |
| JP2020516615A (ja) | 2020-06-11 |
| EP3606542A4 (en) | 2021-01-20 |
| SG11201909334TA (en) | 2019-11-28 |
| AU2023202844A1 (en) | 2023-07-06 |
| US20240066095A1 (en) | 2024-02-29 |
| US20180289770A1 (en) | 2018-10-11 |
| TWI797116B (zh) | 2023-04-01 |
| CA3059354A1 (en) | 2018-10-11 |
| KR20230144097A (ko) | 2023-10-13 |
| WO2018187682A1 (en) | 2018-10-11 |
| AU2018248324B2 (en) | 2023-02-09 |
| US10251933B2 (en) | 2019-04-09 |
| CN110769844B (zh) | 2025-01-21 |
| EP3606542A1 (en) | 2020-02-12 |
| AU2018248324A1 (en) | 2019-10-31 |
| US20200148728A1 (en) | 2020-05-14 |
| US11207376B2 (en) | 2021-12-28 |
| CN110769844A (zh) | 2020-02-07 |
| MX2022008842A (es) | 2022-08-02 |
| IL269853A (en) | 2019-11-28 |
| KR102903277B1 (ko) | 2025-12-23 |
| TW201841649A (zh) | 2018-12-01 |
| KR20200003821A (ko) | 2020-01-10 |
| MX2019012051A (es) | 2020-02-12 |
| JP7789303B2 (ja) | 2025-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022008842A (es) | Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial. | |
| MX2025009223A (es) | Agentes de union a clec9a y su uso | |
| MX2017010336A (es) | Antagonistas de integrina beta7 y métodos para el tratamiento de la enfermedad de crohn. | |
| MX2021002321A (es) | Nuevos metodos. | |
| WO2016196776A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| MY200087A (en) | Rnai agents and compositions for inhibiting expression of angiopoietin-like 3 (angptl3), and methods of use | |
| WO2016004305A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
| MX2020002869A (es) | Compuestos de pirazolopirimidinona y usos de los mismos. | |
| PH12021551455A1 (en) | Jak1 pathway inhibitors for the treatment of gastrointestinal disease | |
| MX375752B (es) | Inhibidores de tirosina quinasa de bruton. | |
| EA201800199A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и снижения веса, композиции, лекарственное стедство | |
| PH12014501815A1 (en) | Purinone compounds as kinase inhibitors | |
| NZ799031A (en) | Solid forms of berberine ursodeoxycholate and compositions and methods thereof | |
| WO2017087608A8 (en) | Modulators of ror-gamma | |
| WO2015112793A3 (en) | Methods of expanding ex vivo natural killer t (nkt) cells and therapeutic uses thereof | |
| EA201490512A1 (ru) | Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека | |
| IN2012DN02645A (enExample) | ||
| MA40057A (fr) | Traitement thérapeutique de maladie cutanée au moyen de micro-organismes cutanés commensaux recombinants | |
| MX2015015784A (es) | Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. | |
| SG10201906400SA (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| EP3502248A4 (en) | ANTIBODIES AGAINST HMGB1 AND COMPOSITION THERE FOR TREATING OR PREVENTING MORBUS ALZHEIMER | |
| EA201690659A1 (ru) | Композиции аморфного магнийзамещенного фосфата кальция и их применение | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| BR112014011744A2 (pt) | formulação de ação sustentável da forma 2 de ciclosporina |